Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2010 Feb;53(1):69-70.

Case Series: tumefactive demyelinating lesions: a diagnostic challenge

Aria Fallah  1 , Sarfaraz Banglawala, Shanil Ebrahim, John E Paulseth, Neilank K Jha
Affiliations
Case Reports

Case Series: tumefactive demyelinating lesions: a diagnostic challenge

Aria Fallah et al. Can J Surg. 2010 Feb.
No abstract available

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
A T1-weighted magnetic resonance imaging scan showed a right frontal lesion with midline shift.
See this image and copyright information in PMC

References

    1. Given CA, 2nd, Stevens BS, Lee C. The MRI appearance of tumefactive demyelinating lesions. AJR Am J Roentgenol. 2004;182:195–9. - PubMed
    1. Tan HM, Chan LL, Chuah KL, et al. Monophasic, solitary tumefactive demyelinating lesion: neuroimaging features and neuropathological diagnosis. Br J Radiol. 2004;77:153–6. - PubMed
    1. Mao-Draayer Y, Braff S, Pendlebury W, et al. Treatment of steroid-unresponsive tumefactive demyelinating disease with plasma exchange. Neurology. 2002;59:1074–7. - PubMed
    1. Saindane AM, Cha S, Law M, et al. Proton MR spectroscopy of tumefactive demyelinating lesions. AJNR Am J Neuroradiol. 2002;23:1378–86. - PMC - PubMed
    1. Cha S, Pierce S, Knopp EA, et al. Dynamic contrast-enhanced T2*-weighted MR imaging of tumefactive demyelinating lesions. AJNR Am J Neuroradiol. 2001;22:1109–16. - PMC - PubMed

Publication types